03 April, 2017
The defect could make it hard to activate the device in an emergency.
The EpiPens affected by the new recall were distributed between December 2015 and July 2016, but Mylan has not yet made clear precisely how many EpiPens are affected. The recalled devices may contain a defective part that could cause the pens to fail to activate.
The products involved in the recall are EpiPen auto-injectors with an expiry date of May 2017, and EpiPen Jr. auto-injectors with an expiry date of March 2017.
Mylan has issued a voluntary recall of select lots of EpiPens in the United States. The Mylan adult version are sold with a yellow label while the EpiPen Jr.is sold with a green label.
EpiPens work by shooting a needle full of adrenaline into your body, which can save your life in the case of an allergic reaction. Meridian Medical Technologies manufactured the devices, which were distributed by Mylan Specialty, the FDA said.More news: The Trump Administration Has Dropped Questions About LGBTQs From the 2020 Census
Mylan, which is the focus of multiple federal investigations, has come under fire for staggering price increases on the emergency shot in the United States.
The U.S. recall follows an worldwide recall of roughly 81,000 EpiPens in Australia, New Zealand, Europe and Japan in March.
The recalled items will be replaced at no cost. The device is a literal lifesaver for people who experience severe allergic reactions, and that's exactly why the company is being pro-active about the issue.
"We are asking patients to keep their existing product until their replacement product can be secured", the company said.